616 related articles for article (PubMed ID: 25960214)
21. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
Shin HN; Moon HH; Ku JL
Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.
Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y
Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186
[TBL] [Abstract][Full Text] [Related]
24. Expression of CXCL12 and CXCR4 in human endometrium; effects of CXCL12 on MMP production by human endometrial cells.
Laird SM; Widdowson R; El-Sheikhi M; Hall AJ; Li TC
Hum Reprod; 2011 May; 26(5):1144-52. PubMed ID: 21357602
[TBL] [Abstract][Full Text] [Related]
25. Role of CXCL12 in metastasis of human ovarian cancer.
Jiang YP; Wu XH; Xing HY; DU XY
Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
[TBL] [Abstract][Full Text] [Related]
26. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
Baek SH; Kim SM; Nam D; Lee JH; Ahn KS; Choi SH; Kim SH; Shim BS; Chang IM; Ahn KS
Pharm Biol; 2012 Oct; 50(10):1210-8. PubMed ID: 22853317
[TBL] [Abstract][Full Text] [Related]
27. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells.
Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Faust SK; Vicinus B; Gräber S; Kollmar O; Schilling MK
J Transl Med; 2011 Feb; 9():22. PubMed ID: 21349176
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
29. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer].
Ding YL; Fu QY; Tang SF; Zhang JL; Li ZY; Li ZT
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):210-3. PubMed ID: 19563077
[TBL] [Abstract][Full Text] [Related]
30. Onbaekwon Suppresses Colon Cancer Cell Invasion by Inhibiting Expression of the CXC Chemokine Receptor 4.
Kim B; Yoon J; Yoon SW; Park B
Integr Cancer Ther; 2017 Jun; 16(2):244-251. PubMed ID: 27160279
[TBL] [Abstract][Full Text] [Related]
31. [Mechanism of EGFR Over-expression and Mutations Leading to
Biological Characteristics Changes of Human Lung Adenocarcinoma Cells
through CXCR4/CXCL12 Signaling Pathway].
Feng J; Wei X; Li C; Guo M; Peng M; Song Q; Han G
Zhongguo Fei Ai Za Zhi; 2018 Jul; 21(7):503-512. PubMed ID: 30037369
[TBL] [Abstract][Full Text] [Related]
32. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
Liu Y; Ren CC; Yang L; Xu YM; Chen YN
J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
Cutler MJ; Lowthers EL; Richard CL; Hajducek DM; Spagnuolo PA; Blay J
BMC Cancer; 2015 Nov; 15():882. PubMed ID: 26552750
[TBL] [Abstract][Full Text] [Related]
34. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
Oh YS; Kim HY; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
Oncol Rep; 2012 Dec; 28(6):2239-46. PubMed ID: 23023480
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
37. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
38. Increased Expression of the YPEL3 Gene in Human Colonic Adenocarcinoma Tissue and the Effects on Proliferation, Migration, and Invasion of Colonic Adenocarcinoma Cells In Vitro via the Wnt/b-Catenin Signaling Pathway.
Kong X; Li Y; Zhang X
Med Sci Monit; 2018 Jul; 24():4767-4775. PubMed ID: 29988027
[TBL] [Abstract][Full Text] [Related]
39. Effects of propofol on colon cancer metastasis through STAT3/HOTAIR axis by activating WIF-1 and suppressing Wnt pathway.
Zhang YF; Li CS; Zhou Y; Lu XH
Cancer Med; 2020 Mar; 9(5):1842-1854. PubMed ID: 31953926
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
Wang C; Wang J; Liu H; Fu Z
Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]